Shaker A. Mousa
The Pharmaceutical research Institute,ACPHS,Albany, USA
Title: Advanced Drug Delivery: Nano-targeted delivery for Therapeutic and Imaging
Biography
Biography: Shaker A. Mousa
Abstract
Targeted delivery of drug incorporated nanoparticles, through conjugation of tumor-specific cell surface markers, such as tumor-specific antibodies or ligands can not only enhance the efficacy of the anticancer drug but also reduce the unwanted toxicity of the drug. Additionally, multifunctional characteristics of the nano-carrier system would allow for simultaneous imaging of tumor mass, targeted drug delivery and monitoring. A summary of recent progress in nanotechnology as it relates specifically to nanoparticles and anticancer drug delivery will be reviewed. Nano Nutraceuticals using combination of various natural products provide a great potential in cancer management. Additionally, various Nanomedicine approaches for the detection and treatment of various types of clots organ specific delivery, vascular targeting, improved PK / PD, and vaccine will be briefly discussed.
Learning Objectives: Highlight the Role of Nanobiotechnology and other enabling technologies in the followings:
- Targeted Drug Delivery
- Improved PK and PD
- Early detection (Imaging)
- Targeted Delivery of Chemotherapy for optimal efficacy and safety
- Nano synthesis and assembly of various platforms for Targeted Delivery
- Nanobiotechnology in shortening the time and risk of Drug Discovery and Development